» Articles » PMID: 32929911

[Inhibitory Effect of MiR-429 on Expressions of ZO-1, Occludin, and Claudin-5 Proteins to Improve the Permeability of Blood Spinal Cord Barrier ]

Overview
Specialty General Surgery
Date 2020 Sep 15
PMID 32929911
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To explore the feasibility and mechanism of inhibiting miR-429 to improve the permeability of the blood spinal cord barrier (BSCB) , and provide a new gene therapy target for enhancing the spinal cord microenvironment.

Methods: First, the immortalized human brain microvascular endothelial cell line (hCMEC/D3) was transfected with the anti-miR-429 antagonist (antagomiR-429) and its negative control (antagomiR-429-NC), respectively. The miR-429 expression of hCMEC/D3 cells was observed by fluorescence microscopy and real-time fluorescence quantitative PCR to verify the transfection efficiency of antagomiR-429. Then the effect of miR-429 on BSCB permeability was observed . The experiment was divided into 4 groups. The blank control group (group A) was constructed of normal hCMEC/D3 cells and Ha-sc cells to prepare the BSCB model, the hypoxia-induced group (group B), the hypoxia-induced+antagomiR-429-NC group (group C), and the hypoxia-induced+antagomiR-429 group (group D) were constructed of normal, antagomiR-429-NC transfected, and antagomiR-429 transfected hCMEC/D3 cells and Ha-sc cells to prepare the BSCB models and hypoxia treatment for 12 hours. The permeability of BSCB was measured by horseradish peroxidase (HRP) permeability. Real-time fluorescence quantitative PCR, Western blot, and immunofluorescence staining were used to observe the expressions of ZO-1, Occludin, and Claudin-5.

Results: The antagomiR-429 and antagomiR-429-NC were successfully transfected into hCMEC/D3 cells under a fluorescence microscope, and the transfection efficiency was about 90%. Real-time fluorescence quantitative PCR results showed that the relative expression of miR-429 in antagomiR-429 group was 0.109±0.013, which was significantly lower than that of antagomiR-429-NC group (0.956±0.004, <0.05). HRP permeability measurement, real-time fluorescence quantitative PCR, and Western blot results showed that the HRP permeability of groups B and C were significantly higher than those of groups A and D ( <0.05), and the relative expressions of ZO-1, Occludin, and Claudin-5 proteins and mRNAs were significantly lower in groups B and C than in groups A and D ( <0.05) and in group D than in group A ( <0.05); there was no significant difference between groups B and C ( >0.05). Immunofluorescence staining showed that the immunofluorescence of ZO-1, Occudin, and Claudin-5 at the cell membrane boundary in group D were stronger than those in groups B and C, but not as strong as that in group A.

Conclusion: Inhibition of miR-429 expression can promote the expressions of ZO-1, Occludin, and Claudin-5 proteins in microvascular endothelial cells, thereby improving the increased permeability of BSCB due to hypoxia.

Citing Articles

Blood-Spinal Cord Barrier: Its Role in Spinal Disorders and Emerging Therapeutic Strategies.

Chopra N, Menounos S, Choi J, Hansbro P, Diwan A, Das A NeuroSci. 2024; 3(1):1-27.

PMID: 39484675 PMC: 11523733. DOI: 10.3390/neurosci3010001.

References
1.
Tong M, He Z, Lin X, Zhou Y, Wang Q, Zheng Z . Lithium chloride contributes to blood-spinal cord barrier integrity and functional recovery from spinal cord injury by stimulating autophagic flux. Biochem Biophys Res Commun. 2017; 495(4):2525-2531. DOI: 10.1016/j.bbrc.2017.12.119. View

2.
Arhart R . A possible haemodynamic mechanism for amyotrophic lateral sclerosis. Med Hypotheses. 2010; 75(4):341-6. DOI: 10.1016/j.mehy.2010.03.017. View

3.
Fan B, Wei Z, Yao X, Shi G, Cheng X, Zhou X . Microenvironment Imbalance of Spinal Cord Injury. Cell Transplant. 2018; 27(6):853-866. PMC: 6050904. DOI: 10.1177/0963689718755778. View

4.
Figueiredo N . Motor exam of patients with spinal cord injury: a terminological imbroglio. Neurol Sci. 2017; 38(7):1159-1165. DOI: 10.1007/s10072-017-2931-8. View

5.
Alvarez-Garcia I, Miska E . MicroRNA functions in animal development and human disease. Development. 2005; 132(21):4653-62. DOI: 10.1242/dev.02073. View